Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Ampio Pharmaceuticals, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Ampio Pharmaceuticals, Inc. | d736423d10q.htm |
| EX-31.1 - EX-31.1 - Ampio Pharmaceuticals, Inc. | d736423dex311.htm |
| EX-31.2 - EX-31.2 - Ampio Pharmaceuticals, Inc. | d736423dex312.htm |
Exhibit 32.1
AMPIO PHARMACEUTICALS, INC. AND SUBSIDIARIES
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended June 30, 2014 (the “Report”) by Ampio Pharmaceuticals, Inc. (the “Company”), each of the undersigned hereby certifies that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Dated: August 8, 2014 | /s/ Michael Macaluso | |
| Michael Macaluso | ||
| Chief Executive Officer | ||
| Dated: August 8, 2014 | /s/ Gregory A. Gould | |
| Gregory A. Gould | ||
| Chief Financial Officer | ||